# Interferon Lambda Therapy for COVID-19

> **NCT04388709** · PHASE2 · WITHDRAWN · sponsor: **Icahn School of Medicine at Mount Sinai**

## Conditions studied

- SARS-CoV-2

## Interventions

- **DRUG:** Peginterferon Lambda-1A

## Key facts

- **NCT ID:** NCT04388709
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-09
- **Primary completion:** 2021-02-05
- **Final completion:** 2021-02-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to the number of competing trials at their site, the study team has closed enrollment and withdrawn this trial.
- **Last updated:** 2021-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04388709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04388709, "Interferon Lambda Therapy for COVID-19". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04388709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*